Schroder Investment Management Group
CHRS icon

Schroder Investment Management Group’s Coherus Oncology CHRS Stock Holding History

Schroder Investment Management Group’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-35,185
Closed -$629K – 1340
2020
Q2 		$629K Sell
35,185
-438,526
-93% -$7.42M ﹤0.01% 969
2020
Q1 		$7.55M Buy
+473,711
New +$8.75M 0.02% 595
2017
Q3 		– Sell
-28,879
Closed -$417K – 1333
2017
Q2 		$417K Buy
+28,879
New +$555K ﹤0.01% 1086

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Schroder Investment Management Group's CHRS Position: Q3 2020 in Review

Schroder Investment Management Group sold out of Coherus Oncology (CHRS) in Q3 2020, closing a stake of 35,185 shares — an estimated $629K sold.

Schroder Investment Management Group first reported a position in CHRS in Q2 2017 and held it in 3 quarters. The position peaked at $7.55M in Q1 2020. 201 funds tracked by Wall St. Rank hold CHRS as of Q3 2020.

  • Schroder Investment Management Group reported no remaining Coherus Oncology position as of Q3 2020 after selling out during the quarter.
  • Schroder Investment Management Group sold 35,185 Coherus Oncology shares in Q3 2020, an estimated $629K.
  • Schroder Investment Management Group first reported a position in Coherus Oncology in Q2 2017 and held it in 3 quarters.
  • Schroder Investment Management Group's Coherus Oncology position peaked at $7.55M in Q1 2020.
  • 201 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2020.

Based on Schroder Investment Management Group's 13F filing for Q3 2020, filed 13 Nov 2020.